InBody Co., Ltd., known for medical-grade body composition analysis, will showcase its solutions at the Aesthetic Medicine India Conference and Exhibition 2025. The event will take place at the Bombay Exhibition Centre, Nesco, Mumbai, from 17 to 18 May.
InBody970
The company will showcase the InBody970, the latest advancement in precise, non-invasive body composition diagnostics. It is designed for clinicians, researchers, and wellness professionals. The design sets a new benchmark with its 3 MHz technology and Direct Segmental Multi-Frequency Bioelectrical Impedance Analysis (DSM-BIA).
Practitioners will experience firsthand how the innovation delivers detailed insights into intracellular and extracellular water, muscle mass, fat mass, and phase angle. These critical parameters are essential for aesthetic, medical, and wellness applications.
The InBody970 features 7 specialised result sheets and age-specific evaluations, powered by InBody’s extensive Big Data database. It will demonstrate how precision diagnostics can drive personalised treatment planning and deliver measurable results.
The innovation also features a sleek, ergonomic design with stainless steel electrodes, prioritising user privacy and comfort. The InBody970 redefines expectations for body composition analysis in aesthetic medicine. Attendees will discover how InBody’s cloud-compatible systems and identification technologies simplify data management, enabling more streamlined, efficient client care.
Complementary technologies
The company will showcase its seamless integration with complementary technologies like the Y scope. This integration offers advanced visceral fat analysis to help aesthetic practitioners target specific health goals. The InBody970 is validated against gold-standard methods like DEXA, CT, and D2O dilution. It ensures clinically reliable data across all demographics, without relying on population-based estimations.
A leader in personalised care
InBody is a trusted partner in over 110 countries, with a database of more than 170 million tests and citations in over 10,000 scientific studies. It continues to lead the industry toward a future where data-driven, personalised healthcare becomes the new standard.
Join InBody at AMI 2025 to experience firsthand how their innovations are shaping the future of aesthetics, preventive diagnostics, and personalised wellness.
Click Here for more details.